activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2470209	CHEMBL983611	Inhibition of LATS1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL6167	Homo sapiens	INH	%	10.0
	2470209	CHEMBL983611	Inhibition of LATS1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL6167	Homo sapiens	INH	%	10.0
	2897834	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897835	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897836	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	470.0	CHEMBL6167	Homo sapiens	Kd	nM	470.0
	2897837	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897838	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897839	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897840	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1700.0	CHEMBL6167	Homo sapiens	Kd	nM	1700.0
	2897841	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897842	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897843	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897844	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897845	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897846	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897847	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897848	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897849	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897850	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897851	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897852	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897853	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897854	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897855	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2600.0	CHEMBL6167	Homo sapiens	Kd	nM	2600.0
	2897856	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897857	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897858	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897859	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1100.0	CHEMBL6167	Homo sapiens	Kd	nM	1100.0
	2897860	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897861	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897862	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897863	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897864	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897865	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897866	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	42.0	CHEMBL6167	Homo sapiens	Kd	nM	42.0
	2897867	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	850.0	CHEMBL6167	Homo sapiens	Kd	nM	850.0
	2897868	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	630.0	CHEMBL6167	Homo sapiens	Kd	nM	630.0
	2897869	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5500.0	CHEMBL6167	Homo sapiens	Kd	nM	5500.0
	2897870	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2897871	CHEMBL1062843	Binding constant for LATS1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	2921296	CHEMBL1049103	Inhibition of LATS1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	76.0	CHEMBL6167	Homo sapiens	Activity	%	76.0
	3331994	CHEMBL1166044	Inhibition of LATS1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	3333409	CHEMBL1166044	Inhibition of LATS1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	3334814	CHEMBL1166044	Inhibition of LATS1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	3336234	CHEMBL1166044	Inhibition of LATS1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	3341776	CHEMBL1166044	Inhibition of LATS1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	3343223	CHEMBL1166044	Inhibition of LATS1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	3358633	CHEMBL1174813	Inhibition of LATS1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	20.0	CHEMBL6167	Homo sapiens	INH	%	20.0
	3359075	CHEMBL1174813	Inhibition of LATS1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	3.4	CHEMBL6167	Homo sapiens	INH	%	3.4
	3445167	CHEMBL1244478	Binding affinity to LATS1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	30.0	CHEMBL6167	Homo sapiens	Kd	nM	30.0
	3448471	CHEMBL1244478	Binding affinity to LATS1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	3448966	CHEMBL1244478	Binding affinity to LATS1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1100.0	CHEMBL6167	Homo sapiens	Kd	nM	1100.0
	3449248	CHEMBL1244478	Binding affinity to LATS1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	630.0	CHEMBL6167	Homo sapiens	Kd	nM	630.0
	3449706	CHEMBL1244478	Binding affinity to LATS1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	3450113	CHEMBL1244478	Binding affinity to LATS1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	3451031	CHEMBL1244478	Binding affinity to LATS1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
	6339902	CHEMBL1826200	Activity of LATS1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	63.0	CHEMBL6167	Homo sapiens	Activity	%	63.0
	7567361	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7567820	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7568317	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7568749	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	850.0	CHEMBL6167	Homo sapiens	Kd	nM	850.0
	7569334	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7569824	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7570287	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7570714	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	630.0	CHEMBL6167	Homo sapiens	Kd	nM	630.0
	7571325	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7571801	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7572264	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7572680	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1600.0	CHEMBL6167	Homo sapiens	Kd	nM	1600.0
	7572849	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7573306	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7573782	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3300.0	CHEMBL6167	Homo sapiens	Kd	nM	3300.0
	7574251	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1100.0	CHEMBL6167	Homo sapiens	Kd	nM	1100.0
	7574659	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	4500.0	CHEMBL6167	Homo sapiens	Kd	nM	4500.0
	7574827	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	420.0	CHEMBL6167	Homo sapiens	Kd	nM	420.0
	7575288	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7575759	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7576224	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7576632	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7576801	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7577260	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7577738	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	5000.0	CHEMBL6167	Homo sapiens	Kd	nM	5000.0
	7578208	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7578809	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	1100.0	CHEMBL6167	Homo sapiens	Kd	nM	1100.0
	7579183	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7579633	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7580107	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7580537	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7581167	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7581552	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7581997	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7582490	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7582890	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	5500.0	CHEMBL6167	Homo sapiens	Kd	nM	5500.0
	7583513	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2100.0	CHEMBL6167	Homo sapiens	Kd	nM	2100.0
	7583910	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7584355	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7584384	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7584846	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7585250	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7585843	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7586251	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7586726	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2600.0	CHEMBL6167	Homo sapiens	Kd	nM	2600.0
	7587180	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7588234	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7588705	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7589156	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7589327	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7589751	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	30.0	CHEMBL6167	Homo sapiens	Kd	nM	30.0
	7590218	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7590692	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7591143	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7591300	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7591722	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1700.0	CHEMBL6167	Homo sapiens	Kd	nM	1700.0
	7592194	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7592667	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7593120	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7593267	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	470.0	CHEMBL6167	Homo sapiens	Kd	nM	470.0
	7593702	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7594174	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7594647	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7595235	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7595679	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7596153	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7596629	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7597207	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7597660	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7598133	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7598161	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	nM	10000.0
	7598603	CHEMBL1908660	Binding constant for LATS1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	42.0	CHEMBL6167	Homo sapiens	Kd	nM	42.0
	12172384	CHEMBL2210649	Inhibition of LATS1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	88.0	CHEMBL6167	Homo sapiens	Activity	%	88.0
	13342306	CHEMBL2394178	Competitive binding affinity to LATS1 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2ccnc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1898211	<	Activity	%	30.0	CHEMBL6167	Homo sapiens	Activity	%	30.0
	13439830	CHEMBL2426975	Competitive binding affinity to LATS1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	13445663	CHEMBL2426975	Competitive binding affinity to LATS1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	13451650	CHEMBL2426975	Competitive binding affinity to LATS1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	15756940	CHEMBL3631270	Inhibition of LATS (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	9.91	CHEMBL6167	Homo sapiens	INH	%	9.91
	15757783	CHEMBL3631270	Inhibition of LATS (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	11.01	CHEMBL6167	Homo sapiens	INH	%	11.01
	15758762	CHEMBL3631270	Inhibition of LATS (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	3.53	CHEMBL6167	Homo sapiens	INH	%	3.53
	16431878	CHEMBL3748232	Inhibition of human LATS1 using [KKRNRRLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL6167	Homo sapiens	IC50	uM	10.0
Inactive	17909052	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909053	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909054	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909055	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909056	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909057	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909058	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909059	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	25.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	25.0
Inactive	17909060	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909061	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909062	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	66.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	66.0
Inactive	17909063	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909064	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909065	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909066	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	2768.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	2768.0
Active	17909067	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	2157.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	2157.0
Inactive	17909068	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909069	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909070	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909071	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909072	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909073	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	=	Kd	nM	3879.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	3879.0
Inactive	17909074	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909075	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909076	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909077	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909078	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909079	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909080	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909081	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909082	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909083	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909084	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909085	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909086	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909087	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909088	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909089	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909090	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909091	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909092	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909093	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909094	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909095	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909096	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909097	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909098	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909099	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909100	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	221.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	221.0
Inactive	17909101	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909102	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909103	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909104	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909105	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909106	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909107	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909108	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	261.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	261.0
Inactive	17909109	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909110	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909111	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909112	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909113	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909114	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909115	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909116	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909117	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909118	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	635.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	635.0
Active	17909119	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Kd	nM	4170.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	4170.0
Inactive	17909120	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909121	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909122	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17909123	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Kd	nM	3592.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	3592.0
Inactive	17909124	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909125	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	3790.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	3790.0
Inactive	17909126	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909127	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909128	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909129	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909130	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909131	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909132	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	74.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	74.0
Inactive	17909133	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909134	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909135	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	743.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	743.0
Inactive	17909136	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909137	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909138	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909139	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909140	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909141	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909142	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909143	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909144	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909145	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909146	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909147	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909148	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909149	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909150	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909151	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909152	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909153	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909154	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909155	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909156	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909157	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909158	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909159	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909160	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	406.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	406.0
Inactive	17909161	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909162	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909163	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909164	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909165	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909166	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909167	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909168	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909169	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909170	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909171	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909172	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909173	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909174	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909175	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909176	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909177	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909178	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909179	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909180	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909181	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	14.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	14.0
Inactive	17909182	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909183	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909184	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909185	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909186	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909187	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	955.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	955.0
Inactive	17909188	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909189	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909190	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909191	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909192	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909193	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909194	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909195	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909196	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909197	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909198	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909199	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909200	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909201	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909202	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909203	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	67.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	67.0
Inactive	17909204	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909205	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909206	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909207	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909208	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909209	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909210	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909211	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	1884.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	1884.0
Inactive	17909212	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909213	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909214	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	=	Kd	nM	14103.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	14103.0
Active	17909215	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	=	Kd	nM	27.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	27.0
Inactive	17909216	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909217	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909218	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909219	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	10733.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	10733.0
Inactive	17909220	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909221	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909222	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909223	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909224	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909225	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909226	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909227	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909228	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909229	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909230	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909231	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909232	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	4616.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	4616.0
Inactive	17909233	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909234	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909235	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909236	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909237	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909238	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909239	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909240	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909241	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909242	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909243	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909244	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909245	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909246	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909247	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909248	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909249	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909250	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909251	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	9050.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	9050.0
Inactive	17909252	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909253	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909254	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909255	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909256	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909257	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	363.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	363.0
Active	17909258	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	681.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	681.0
Inactive	17909259	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909260	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909261	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909262	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	157.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	157.0
Inactive	17909263	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909264	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909265	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909266	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909267	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909268	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909269	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	=	Kd	nM	195.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	195.0
Inactive	17909270	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909271	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	3011.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	3011.0
Inactive	17909272	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Active	17909273	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	45.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	45.0
Inactive	17909274	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909275	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909276	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909277	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909278	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909279	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909280	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909281	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909282	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909283	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909284	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909285	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909286	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909287	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909288	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909289	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909290	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909291	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909292	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909293	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17909294	CHEMBL3991746	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL6167	Homo sapiens	Kd apparent	nM	30000.0
	18114290	CHEMBL4025204	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	74.0	CHEMBL6167	Homo sapiens	Activity	%	74.0
	18153297	CHEMBL4034360	Inhibition of LATS1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-7.7	CHEMBL6167	Homo sapiens	INH	%	-7.7
	18153298	CHEMBL4034359	Inhibition of LATS1 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-1.2	CHEMBL6167	Homo sapiens	INH	%	-1.2
	18203728	CHEMBL4044015	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL6167	Homo sapiens	Activity	%	100.0
	18211584	CHEMBL4045719	Inhibition of LATS1 conserved Lys2 (DIKPDNILIDR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	30.9	CHEMBL6167	Homo sapiens	INH	%	30.9
	18211599	CHEMBL4045718	Inhibition of LATS1 conserved Lys1 (ALYATKTLR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	30.1	CHEMBL6167	Homo sapiens	INH	%	30.1
	18211863	CHEMBL4045959	Inhibition of LATS1 conserved Lys1 (ALYATKTLR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	23.1	CHEMBL6167	Homo sapiens	INH	%	23.1
	18211864	CHEMBL4045960	Inhibition of LATS1 conserved Lys2 (DIKPDNILIDR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	34.9	CHEMBL6167	Homo sapiens	INH	%	34.9
	18253608	CHEMBL4055088	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	91.0	CHEMBL6167	Homo sapiens	Activity	%	91.0
	18253609	CHEMBL4055088	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	90.0	CHEMBL6167	Homo sapiens	Activity	%	90.0
	18274995	CHEMBL4118377	Inhibition of LATS1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled ALYATKTLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	17.5	CHEMBL6167	Homo sapiens	INH	%	17.5
	18274996	CHEMBL4118377	Inhibition of LATS1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled ALYATKTLR probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	5.3	CHEMBL6167	Homo sapiens	INH	%	5.3
	18274997	CHEMBL4118377	Inhibition of LATS1 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled ALYATKTLR probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	9.9	CHEMBL6167	Homo sapiens	INH	%	9.9
	18440270	CHEMBL4157094	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL6167	Homo sapiens	Activity	%	100.0
	18484226	CHEMBL4185873	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL6167	Homo sapiens	Activity	%	99.0
	18484710	CHEMBL4185873	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL6167	Homo sapiens	Activity	%	100.0
	18653563	CHEMBL4230122	Inhibition of LATS1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-4.0	CHEMBL6167	Homo sapiens	INH	%	-4.0
	18653564	CHEMBL4230122	Inhibition of LATS1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	3.0	CHEMBL6167	Homo sapiens	INH	%	3.0
	18655462	CHEMBL4230773	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	98.0	CHEMBL6167	Homo sapiens	Activity	%	98.0
	18751022	CHEMBL4263840	Inhibition of LATS1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	4.0	CHEMBL6167	Homo sapiens	INH	%	4.0
	18752035	CHEMBL4264362	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	96.0	CHEMBL6167	Homo sapiens	Activity	%	96.0
	18858026	CHEMBL4307872	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL6167	Homo sapiens	Activity	%	96.0
	18938027	CHEMBL4327740	Inhibition of human LATS1 assessed as residual activity at 1 uM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	98.72	CHEMBL6167	Homo sapiens	Activity	%	98.72
	18938028	CHEMBL4327740	Inhibition of human LATS1 assessed as residual activity at 1 uM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.29	CHEMBL6167	Homo sapiens	Activity	%	98.29
	18938585	CHEMBL4328104	Inhibition of human LATS1 assessed as residual activity at 100 uM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL6167	Homo sapiens	Activity	%	65.0
	18938965	CHEMBL4328468	Inhibition of human LATS1 using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	12.8	CHEMBL6167	Homo sapiens	IC50	10'-8M	1.28
	18958937	CHEMBL4333459	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	98.0	CHEMBL6167	Homo sapiens	Activity	%	98.0
	18964395	CHEMBL4335135	Inhibition of human LATS1 assessed as residual activity at 1 uM by radiometric assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	114.0	CHEMBL6167	Homo sapiens	Activity	%	114.0
	18972180	CHEMBL4337191	Binding affinity to recombinant human LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as dissociation constant by Kinomescan method	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	>	Kd	nM	10000.0	CHEMBL6167	Homo sapiens	Kd	uM	10.0
Dose-dependent effect	19012391	CHEMBL4345740	Activation of LATS1 in triple-negative human SUM159 cells transfected with YAP/TAZ-TEAD reporter plasmid containing 8xGTIIC binding site and cotransfected with pCMV-Luc assessed as suppression of YAP/TAZ luciferase activity measured after 12 hrs by dual luciferase reporter assay	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012392	CHEMBL4345741	Activation of LATS1 in triple-negative human SUM159 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.25 to 1 uM measured after 12 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Not Active	19012393	CHEMBL4345742	Activation of LATS1 in triple-negative human SUM159 cells assessed as effect on YAP mRNA level at 0.25 to 1 uM measured after 12 hrs by Trizol reagent based RT-PCR analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Not Active	19012394	CHEMBL4345743	Activation of LATS1 in triple-negative human SUM159 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.25 to 1 uM measured after 12 hrs in presence of 10 uM proteosomal inhibitor, MG132 by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012395	CHEMBL4345744	Activation of LATS1 in human MDA-MB-231 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.5 uM pretreated with compound for 24 hrs followed by incubation with protein synthesis inhibitor, CHX up to 48 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012410	CHEMBL4345753	Activation of LATS1 in human SUM159 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012411	CHEMBL4345754	Activation of LATS1 in human MDA-MB-321 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012412	CHEMBL4345755	Activation of LATS1 in human PC3 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012413	CHEMBL4345756	Activation of LATS1 in human PC9 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Not Active	19012414	CHEMBL4345757	Activation of LATS1 in human SUM159 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 24 to 48 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Not Active	19012415	CHEMBL4345758	Activation of LATS1 in human MDA-MB-231 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 24 to 48 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Not Active	19012416	CHEMBL4345759	Activation of LATS1 in human PC3 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 24 to 48 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Not Active	19012417	CHEMBL4345760	Activation of LATS1 in human PC9 cells assessed as increase in YAP phosphorylation at Ser397 at 0.25 to 1.5 uM measured after 24 to 48 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Dose-dependent effect	19012422	CHEMBL4345765	Activation of LATS1 in human MDA-MB-231 cells assessed as increase in phosphorylation at Ser909 residue measured after 24 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Dose-dependent effect	19012423	CHEMBL4345766	Activation of LATS1 in human MDA-MB-231 cells assessed as increase in phosphorylation at Thr1079 residue measured after 24 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Dose-dependent effect	19012424	CHEMBL4345767	Activation of LATS1 in human SUM159 cells assessed as increase in phosphorylation at Ser909 residue measured after 12 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Dose-dependent effect	19012425	CHEMBL4345768	Activation of LATS1 in human SUM159 cells assessed as increase in phosphorylation at Thr1079 residue measured after 12 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Dose-dependent effect	19012426	CHEMBL4345769	Activation of LATS1 in human PC3 cells assessed as increase in phosphorylation at Ser909 residue measured after 24 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Dose-dependent effect	19012427	CHEMBL4345770	Activation of LATS1 in human PC3 cells assessed as increase in phosphorylation at Thr1079 residue measured after 24 hrs by Western blot analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012460	CHEMBL4345803	Activation of LATS1 in human SUM159 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012461	CHEMBL4345804	Activation of LATS1 in human MDA-MB-231 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012462	CHEMBL4345805	Activation of LATS1 in human PC3 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19012463	CHEMBL4345806	Activation of LATS1 in human PC9 cells assessed as induction of YAP degradation by measuring suppression of YAP protein expression at 0.25 to 1.5 uM measured after 12 to 24 hrs by immunoblotting analysis	B	CC(=O)Nc1ccc(NC(=O)Nc2cccc(-c3nc(-c4ccc(NC(=O)c5cccnc5)cc4Cl)no3)c2)cc1C(F)(F)F		CHEMBL4593515		Activity			CHEMBL6167	Homo sapiens	Activity		
Active	19041157	CHEMBL4352418	Inhibition of human LATS1 at 10 uM using KKRNRRLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL6167	Homo sapiens	INH		
	19059650	CHEMBL4357951	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL6167	Homo sapiens	Activity	%	100.0
	19090215	CHEMBL4365789	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	85.0	CHEMBL6167	Homo sapiens	Activity	%	85.0
	19091977	CHEMBL4366451	Inhibition of human LATS1 at 100 nM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.07	CHEMBL6167	Homo sapiens	INH	%	10.07
	19159478	CHEMBL4382582	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	82.0	CHEMBL6167	Homo sapiens	Activity	%	82.0
	19191529	CHEMBL4389301	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	14.0	CHEMBL6167	Homo sapiens	INH	%	14.0
	19191964	CHEMBL4389778	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	52.0	CHEMBL6167	Homo sapiens	INH	%	52.0
	19200220	CHEMBL4391404	Binding affinity to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	90.0	CHEMBL6167	Homo sapiens	Activity	%	90.0
	19266474	CHEMBL4405424	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL6167	Homo sapiens	INH	%	50.0
	19350308	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(CC)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4531857	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350309	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C1CC1		CHEMBL4472285	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350310	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(c1nc(-c2ccncc2)nc2cnccc12)C(C)C		CHEMBL4472973	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350311	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(Nc1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4592699	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350312	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)N(C)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4558207	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350313	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4464251	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350314	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COCC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4471995	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350315	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COCCC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4470612	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350316	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCCN(C)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4591428	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350317	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(C)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4447677	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350318	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(COCCO)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4436873	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350319	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)COCC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4574721	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350320	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4446448	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350321	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4472817	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350322	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C1CCCCC1		CHEMBL4465888	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350323	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncc3)nc3cnccc23)COC1		CHEMBL4450377	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350324	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1CCCC1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4446730	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350325	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@H]1CCC[C@H]1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4463415	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350326	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@@H]1CCC[C@@H]1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4463018	=	IC50	nM	0.9	CHEMBL6167	Homo sapiens	IC50	uM	0.0009
	19350327	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(O)C(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4562948	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350328	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4577449	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350329	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CCc1ccccc1)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4438062	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350330	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	c1cc(-c2nc(NC3CC3)c3ccncc3n2)ccn1		CHEMBL4457324	=	IC50	nM	7.0	CHEMBL6167	Homo sapiens	IC50	uM	0.007
	19350331	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CCS(C)(=O)=O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4589113	=	IC50	nM	7.0	CHEMBL6167	Homo sapiens	IC50	uM	0.007
	19350332	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(CO)(CO)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4580434	=	IC50	nM	10.0	CHEMBL6167	Homo sapiens	IC50	uM	0.01
	19350333	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(O)C(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4550313	=	IC50	nM	17.0	CHEMBL6167	Homo sapiens	IC50	uM	0.017
	19350334	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(COCC(=O)O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4547251	=	IC50	nM	30.0	CHEMBL6167	Homo sapiens	IC50	uM	0.03
	19350335	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O[C@@H]1CCC[C@@H]1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4449045	=	IC50	nM	31.0	CHEMBL6167	Homo sapiens	IC50	uM	0.031
	19350336	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCCC(Nc1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4582673	=	IC50	nM	35.0	CHEMBL6167	Homo sapiens	IC50	uM	0.035
	19350337	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CS(C)(=O)=O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4586256	=	IC50	nM	36.0	CHEMBL6167	Homo sapiens	IC50	uM	0.036
	19350338	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@](Nc1nc(-c2ccncc2)nc2cnccc12)(C(=O)O)C(F)(F)F		CHEMBL4551662	=	IC50	nM	36.0	CHEMBL6167	Homo sapiens	IC50	uM	0.036
	19350339	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CNCC(=O)O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4522448	=	IC50	nM	39.0	CHEMBL6167	Homo sapiens	IC50	uM	0.039
	19350340	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@@](Nc1nc(-c2ccncc2)nc2cnccc12)(C(=O)O)C(F)(F)F		CHEMBL4444552	=	IC50	nM	41.0	CHEMBL6167	Homo sapiens	IC50	uM	0.041
	19350341	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COC(=O)C(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4572425	=	IC50	nM	47.0	CHEMBL6167	Homo sapiens	IC50	uM	0.047
	19350342	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O[C@H]1CCC[C@@H]1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4461657	=	IC50	nM	71.0	CHEMBL6167	Homo sapiens	IC50	uM	0.071
	19350343	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C(=O)O		CHEMBL4451071	=	IC50	nM	95.0	CHEMBL6167	Homo sapiens	IC50	uM	0.095
	19350344	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCCOCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4442477	=	IC50	nM	118.0	CHEMBL6167	Homo sapiens	IC50	uM	0.118
	19350345	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCC(CO)(CO)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4518541	=	IC50	nM	199.0	CHEMBL6167	Homo sapiens	IC50	uM	0.199
	19350346	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CC(=O)O)NC(=O)CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4456449	=	IC50	nM	233.0	CHEMBL6167	Homo sapiens	IC50	uM	0.233
	19350347	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C(Cc1ccccc1)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4589539	=	IC50	nM	240.0	CHEMBL6167	Homo sapiens	IC50	uM	0.24
	19350348	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(C)C1(CNc2nc(-c3ccncc3)nc3cnccc23)CCOCC1		CHEMBL4566871	=	IC50	nM	244.0	CHEMBL6167	Homo sapiens	IC50	uM	0.244
	19350349	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CC(=O)O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4577102	=	IC50	nM	328.0	CHEMBL6167	Homo sapiens	IC50	uM	0.328
	19350350	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CS(=O)(=O)CCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4472604	=	IC50	nM	708.0	CHEMBL6167	Homo sapiens	IC50	uM	0.708
	19350351	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C12CC3CC(CC(C3)C1)C2		CHEMBL4464290	=	IC50	nM	711.0	CHEMBL6167	Homo sapiens	IC50	uM	0.711
	19350352	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)C(=O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4445195	>	IC50	nM	1970.0	CHEMBL6167	Homo sapiens	IC50	uM	1.97
	19350353	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O=C(O)CC(Nc1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4521565	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350354	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4459603	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350355	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	c1cc(-c2nc(NCCCc3nnn[nH]3)c3ccncc3n2)ccn1		CHEMBL4527396	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350356	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(N(C)c1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4439529	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350357	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@H](N(C)c1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4572019	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350358	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@@H](N(C)c1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4476180	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350359	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4533967	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350360	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)C(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4562711	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350361	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCC1(Nc2nc(-c3ccncc3)nc3cnccc23)CCCC1		CHEMBL4583241	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350362	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COC1CC(Nc2nc(-c3ccncc3)nc3cnccc23)C1		CHEMBL4446345	=	IC50	nM	12.0	CHEMBL6167	Homo sapiens	IC50	uM	0.012
	19350363	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN[C@@H]1CCCC[C@H]1N(C)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4562357	=	IC50	nM	40.0	CHEMBL6167	Homo sapiens	IC50	uM	0.04
	19350364	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COC(=O)[C@H]1C[C@@H](Nc2nc(-c3ccncc3)nc3cnccc23)C1		CHEMBL4449726	=	IC50	nM	78.0	CHEMBL6167	Homo sapiens	IC50	uM	0.078
	19350365	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCOC(=O)C1(Nc2nc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4443872	=	IC50	nM	460.0	CHEMBL6167	Homo sapiens	IC50	uM	0.46
	19350366	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O=C(O)C1(Nc2nc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4582089	=	IC50	nM	1160.0	CHEMBL6167	Homo sapiens	IC50	uM	1.16
	19350367	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O=C(O)[C@H]1C[C@@H](Nc2nc(-c3ccncc3)nc3cnccc23)C1		CHEMBL4439132	=	IC50	nM	1440.0	CHEMBL6167	Homo sapiens	IC50	uM	1.44
	19350368	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4571192	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350369	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4551441	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350370	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4467179	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350371	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CCO)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4518582	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350372	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C1(Nc2nc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4577857	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350373	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4472306	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350374	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C1(Nc2nc(-c3ccncc3)nc3cnccc23)CC1		CHEMBL4517252	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350375	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	c1cc(-c2nc(NC3CCCC3)c3ccncc3n2)ccn1		CHEMBL4547445	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350376	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CO)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4532021	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350377	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(CO)(Nc1nc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4514630	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350378	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCC(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4437570	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350379	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC[C@H](C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4471884	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350380	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC[C@@H](C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4462244	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350381	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C#CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4451115	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350382	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@]1(Nc2nc(-c3ccncc3)nc3cnccc23)C[C@@H](O)C1		CHEMBL4463150	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350383	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)C(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4566869	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350384	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4578137	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350385	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCC(CC)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4439340	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350386	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CN1CCOCC1)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4448758	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350387	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(COC(C)(C)C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4537258	=	IC50	nM	8.0	CHEMBL6167	Homo sapiens	IC50	uM	0.008
	19350388	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCC(CC(F)(F)F)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4440480	=	IC50	nM	9.0	CHEMBL6167	Homo sapiens	IC50	uM	0.009
	19350389	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4450846	=	IC50	nM	9.0	CHEMBL6167	Homo sapiens	IC50	uM	0.009
	19350390	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCC(CO)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4461047	=	IC50	nM	11.0	CHEMBL6167	Homo sapiens	IC50	uM	0.011
	19350391	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Cc1c[nH]c2ccccc12)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4446641	=	IC50	nM	11.0	CHEMBL6167	Homo sapiens	IC50	uM	0.011
	19350392	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Cc1ccc(F)cc1)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4569437	=	IC50	nM	11.0	CHEMBL6167	Homo sapiens	IC50	uM	0.011
	19350393	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)c1ccccc1		CHEMBL4544743	=	IC50	nM	11.0	CHEMBL6167	Homo sapiens	IC50	uM	0.011
	19350394	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Fc1ccccc1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4454934	=	IC50	nM	13.0	CHEMBL6167	Homo sapiens	IC50	uM	0.013
	19350395	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)c1ccc(F)cc1		CHEMBL4581198	=	IC50	nM	17.0	CHEMBL6167	Homo sapiens	IC50	uM	0.017
	19350396	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(Nc1nc(-c2ccncc2)nc2cnccc12)(C(=O)O)C(F)(F)F		CHEMBL4452896	=	IC50	nM	21.0	CHEMBL6167	Homo sapiens	IC50	uM	0.021
	19350397	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4581418	=	IC50	nM	25.0	CHEMBL6167	Homo sapiens	IC50	uM	0.025
	19350398	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4464254	=	IC50	nM	26.0	CHEMBL6167	Homo sapiens	IC50	uM	0.026
	19350399	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OC1(CNc2nc(-c3ccncc3)nc3cnccc23)CCCC1		CHEMBL4579078	=	IC50	nM	30.0	CHEMBL6167	Homo sapiens	IC50	uM	0.03
	19350400	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(C)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4516885	=	IC50	nM	37.0	CHEMBL6167	Homo sapiens	IC50	uM	0.037
	19350401	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1ccccc1Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4451092	=	IC50	nM	44.0	CHEMBL6167	Homo sapiens	IC50	uM	0.044
	19350402	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1ccc(Nc2nc(-c3ccncc3)nc3cnccc23)cc1		CHEMBL4436050	=	IC50	nM	126.0	CHEMBL6167	Homo sapiens	IC50	uM	0.126
	19350403	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COc1ccc(Nc2nc(-c3ccncc3)nc3cnccc23)cc1		CHEMBL4463357	=	IC50	nM	148.0	CHEMBL6167	Homo sapiens	IC50	uM	0.148
	19350404	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	c1ccc(Nc2nc(-c3ccncc3)nc3cnccc23)cc1		CHEMBL4533517	=	IC50	nM	304.0	CHEMBL6167	Homo sapiens	IC50	uM	0.304
	19350405	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1cccc(Nc2nc(-c3ccncc3)nc3cnccc23)c1		CHEMBL4522043	=	IC50	nM	809.0	CHEMBL6167	Homo sapiens	IC50	uM	0.809
	19350406	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O=C(O)CCCCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4549078	=	IC50	nM	1150.0	CHEMBL6167	Homo sapiens	IC50	uM	1.15
	19350407	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Fc1cccc(Nc2nc(-c3ccncc3)nc3cnccc23)c1		CHEMBL4451658	>	IC50	nM	1440.0	CHEMBL6167	Homo sapiens	IC50	uM	1.44
	19350408	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Fc1ccc(Nc2nc(-c3ccncc3)nc3cnccc23)cc1		CHEMBL4582394	>	IC50	nM	1700.0	CHEMBL6167	Homo sapiens	IC50	uM	1.7
	19350409	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	O=C(O)CCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4455768	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350410	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(Nc1nc(-c2ccncc2)nc2cnccc12)c1ccccc1		CHEMBL4472870	=	IC50	nM	1350.0	CHEMBL6167	Homo sapiens	IC50	uM	1.35
	19350411	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncc3)nc3cnccc23)CC1		CHEMBL4443335	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350412	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CNC(=O)OC(C)(C)C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4461498	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350413	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCC1(Nc2nc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4529548	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350414	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COC(=O)CC1(Nc2nc(-c3ccncc3)nc3cnccc23)CC1		CHEMBL4553844	=	IC50	nM	126.0	CHEMBL6167	Homo sapiens	IC50	uM	0.126
	19350415	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4436796	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350416	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CC#N)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4450536	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350417	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	NCCCCCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4577658	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350418	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	NCCCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4439149	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350419	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C#N)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4453593	=	IC50	nM	8.0	CHEMBL6167	Homo sapiens	IC50	uM	0.008
	19350420	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1CCCCN1CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4545883	=	IC50	nM	27.0	CHEMBL6167	Homo sapiens	IC50	uM	0.027
	19350421	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(C)CCC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4564805	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350422	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CN)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4447080	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350423	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)c1n[nH]cc1-c1nc(NC2CCCC2)c2ccncc2n1		CHEMBL4576185	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350424	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2ccnc(N)c2)nc2cnccc12		CHEMBL4440182	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350425	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1c(-c2nc(NC(C)(C)C)c3ccncc3n2)c2cccnc2n1S(=O)(=O)c1ccccc1		CHEMBL4455852	=	IC50	nM	235.0	CHEMBL6167	Homo sapiens	IC50	uM	0.235
	19350426	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1[nH]c2ncccc2c1-c1nc(NC(C)(C)C)c2ccncc2n1		CHEMBL4460905	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350427	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2c[nH]nc2C(F)(F)F)nc2cnccc12		CHEMBL4592930	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350428	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4520049	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350429	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1cnccc1-c1nc(NC(C)(C)C)c2ccncc2n1		CHEMBL4462002	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350430	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCC(C)(C)Nc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4470520	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350431	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)CC(C)(C)Nc1nc(-c2c[nH]nc2C(F)(F)F)nc2cnccc12		CHEMBL4534660	=	IC50	nM	9.0	CHEMBL6167	Homo sapiens	IC50	uM	0.009
	19350432	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(c1nc(-c2ccncc2F)nc2cnccc12)C(C)C		CHEMBL4522938	=	IC50	nM	10.0	CHEMBL6167	Homo sapiens	IC50	uM	0.01
	19350433	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)COCC(C)(C)Nc1nc(-c2c[nH]nc2C(F)(F)F)nc2cnccc12		CHEMBL4452451	=	IC50	nM	14.0	CHEMBL6167	Homo sapiens	IC50	uM	0.014
	19350434	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)N(C)c1nc(-c2ccncc2F)nc2cnccc12		CHEMBL4568040	=	IC50	nM	15.0	CHEMBL6167	Homo sapiens	IC50	uM	0.015
	19350435	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(c1nc(-c2ccncc2C)nc2cnccc12)C(C)C		CHEMBL4472409	=	IC50	nM	18.0	CHEMBL6167	Homo sapiens	IC50	uM	0.018
	19350436	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COCC(C)(C)Nc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4538846	=	IC50	nM	22.0	CHEMBL6167	Homo sapiens	IC50	uM	0.022
	19350437	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)CC(C)(C)Nc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4475979	=	IC50	nM	23.0	CHEMBL6167	Homo sapiens	IC50	uM	0.023
	19350438	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Clc1cnccc1-c1nc(NC2CCCC2)c2ccncc2n1		CHEMBL4474308	=	IC50	nM	53.0	CHEMBL6167	Homo sapiens	IC50	uM	0.053
	19350439	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)COCC(C)(C)Nc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4542502	=	IC50	nM	55.0	CHEMBL6167	Homo sapiens	IC50	uM	0.055
	19350440	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1cnccc1-c1nc(N(C)C(C)C)c2ccncc2n1		CHEMBL4532329	=	IC50	nM	77.0	CHEMBL6167	Homo sapiens	IC50	uM	0.077
	19350441	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CCS(C)(=O)=O)Nc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4458991	=	IC50	nM	187.0	CHEMBL6167	Homo sapiens	IC50	uM	0.187
	19350442	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2ccncc2C(F)(F)F)nc2cnccc12		CHEMBL4546105	=	IC50	nM	1153.0	CHEMBL6167	Homo sapiens	IC50	uM	1.153
	19350443	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2cc(Cl)ncc2C(F)(F)F)nc2cnccc12		CHEMBL4559476	>	IC50	nM	833.0	CHEMBL6167	Homo sapiens	IC50	uM	0.833
	19350444	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Clc1cnccc1-c1nc(NCCCc2nnn[nH]2)c2ccncc2n1		CHEMBL4458000	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350445	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]cc1-c1nc(NC2(C)CC2)c2ccncc2n1		CHEMBL4585067	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350446	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2F)nc2cnccc12)C(F)(F)F		CHEMBL4555291	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350447	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]cc1-c1nc(NC(C)(C)C(F)(F)F)c2ccncc2n1		CHEMBL4517907	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350448	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@H](N(C)c1nc(-c2ccncc2F)nc2cnccc12)C(F)(F)F		CHEMBL4563697	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350449	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@@H](N(C)c1nc(-c2ccncc2F)nc2cnccc12)C(F)(F)F		CHEMBL4566878	=	IC50	nM	22.0	CHEMBL6167	Homo sapiens	IC50	uM	0.022
	19350450	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccnc(N)c3)nc3cnccc23)CC1		CHEMBL4591733	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350451	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2ccncc2Cl)nc2cnccc12)C(F)(F)F		CHEMBL4513243	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350452	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]cc1-c1nc(NC(C)(C)CC(C)(C)O)c2ccncc2n1		CHEMBL4470043	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350453	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncc3C#N)nc3cnccc23)CC1		CHEMBL4533936	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350454	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2c(C)[nH]c3ncccc23)nc2cnccc12		CHEMBL4466285	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350455	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccc4[nH]ncc4c3)nc3cnccc23)CC1		CHEMBL4546314	=	IC50	nM	7.0	CHEMBL6167	Homo sapiens	IC50	uM	0.007
	19350456	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]c(C)c1-c1nc(NC(C)(C)C(F)(F)F)c2ccncc2n1		CHEMBL4453243	=	IC50	nM	10.0	CHEMBL6167	Homo sapiens	IC50	uM	0.01
	19350457	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(Nc1nc(-c2c[nH]nc2C(F)(F)F)nc2cnccc12)C(F)(F)F		CHEMBL4472559	=	IC50	nM	12.0	CHEMBL6167	Homo sapiens	IC50	uM	0.012
	19350458	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)CC(C)(C)Nc1nc(-c2ccncc2C#N)nc2cnccc12		CHEMBL4450745	=	IC50	nM	33.0	CHEMBL6167	Homo sapiens	IC50	uM	0.033
	19350459	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3c(F)cncc3F)nc3cnccc23)CC1		CHEMBL4471243	=	IC50	nM	69.0	CHEMBL6167	Homo sapiens	IC50	uM	0.069
	19350460	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccnc(F)c3F)nc3cnccc23)CC1		CHEMBL4527745	=	IC50	nM	168.0	CHEMBL6167	Homo sapiens	IC50	uM	0.168
	19350461	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3cncs3)nc3cnccc23)CC1		CHEMBL4561290	=	IC50	nM	171.0	CHEMBL6167	Homo sapiens	IC50	uM	0.171
	19350462	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccnc(C(F)(F)F)c3)nc3cnccc23)CC1		CHEMBL4532757	=	IC50	nM	4270.0	CHEMBL6167	Homo sapiens	IC50	uM	4.27
	19350463	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccnc(C#N)c3)nc3cnccc23)CC1		CHEMBL4472108	>	IC50	nM	10000.0	CHEMBL6167	Homo sapiens	IC50	uM	10.0
	19350464	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3cnoc3)nc3cnccc23)CC1		CHEMBL4533370	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350465	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1noc(C)c1-c1nc(NC2(C)CC2)c2ccncc2n1		CHEMBL4576866	>	IC50	nM	5000.0	CHEMBL6167	Homo sapiens	IC50	uM	5.0
	19350466	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccnc4[nH]ccc34)nc3cnccc23)CC1	Outside typical range	CHEMBL4571918	=	IC50	nM	0.0	CHEMBL6167	Homo sapiens	IC50	uM	0.0
	19350467	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2c[nH]c3ncccc23)nc2cnccc12		CHEMBL4450447	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350468	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-n2ccc3ncccc32)nc2cnccc12		CHEMBL4459333	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350469	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1cnccc1-c1nc(NC(C)(C)C(F)(F)F)c2ccncc2n1		CHEMBL4446164	=	IC50	nM	6.0	CHEMBL6167	Homo sapiens	IC50	uM	0.006
	19350470	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3cn[nH]c3)nc3cnccc23)CCC1		CHEMBL4443123	=	IC50	nM	8.0	CHEMBL6167	Homo sapiens	IC50	uM	0.008
	19350471	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncn3)nc3cnccc23)CC1		CHEMBL4552944	=	IC50	nM	16.0	CHEMBL6167	Homo sapiens	IC50	uM	0.016
	19350472	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]c(C)c1-c1nc(NC(C)(C)CC(C)(C)O)c2ccncc2n1		CHEMBL4437922	=	IC50	nM	24.0	CHEMBL6167	Homo sapiens	IC50	uM	0.024
	19350473	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2c[nH]c3ncncc23)nc2cnccc12		CHEMBL4516822	=	IC50	nM	25.0	CHEMBL6167	Homo sapiens	IC50	uM	0.025
	19350474	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4525661	=	IC50	nM	49.0	CHEMBL6167	Homo sapiens	IC50	uM	0.049
	19350475	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2c[nH]nc2C2CC2)nc2cnccc12		CHEMBL4446508	=	IC50	nM	51.0	CHEMBL6167	Homo sapiens	IC50	uM	0.051
	19350476	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2ccncc2C)nc2cnccc12		CHEMBL4440637	=	IC50	nM	159.0	CHEMBL6167	Homo sapiens	IC50	uM	0.159
	19350477	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2cn(C)c3ncccc23)nc2cnccc12		CHEMBL4562730	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350478	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)CC(C)(C)Nc1nc(-c2cn[nH]c2)nc2cnccc12		CHEMBL4588897	=	IC50	nM	14.0	CHEMBL6167	Homo sapiens	IC50	uM	0.014
	19350479	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@@H](Nc1nc(-c2cn[nH]c2)nc2cnccc12)c1ccccc1		CHEMBL4472484	=	IC50	nM	143.0	CHEMBL6167	Homo sapiens	IC50	uM	0.143
	19350480	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1[nH]ncc1-c1nc(N[C@H](C)c2ccccc2)c2ccncc2n1		CHEMBL4483329	=	IC50	nM	28.0	CHEMBL6167	Homo sapiens	IC50	uM	0.028
	19350481	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(c1nc(-c2cnn(C)c2)nc2cnccc12)C1(C)CC1		CHEMBL4444537	=	IC50	nM	98.0	CHEMBL6167	Homo sapiens	IC50	uM	0.098
	19350482	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	C[C@@H](Nc1nc(-c2ccnn2C)nc2cnccc12)c1ccccc1		CHEMBL4459831	=	IC50	nM	1280.0	CHEMBL6167	Homo sapiens	IC50	uM	1.28
	19350483	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(c1nc(-c2cn[nH]c2)nc2cnccc12)C1(C)CC1		CHEMBL4447802	=	IC50	nM	54.0	CHEMBL6167	Homo sapiens	IC50	uM	0.054
	19350484	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1nccc1-c1nc(NC2(C)CC2)c2ccncc2n1		CHEMBL4445991	=	IC50	nM	17.0	CHEMBL6167	Homo sapiens	IC50	uM	0.017
	19350485	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCn1nccc1-c1nc(NC2(C)CC2)c2ccncc2n1		CHEMBL4578145	=	IC50	nM	61.0	CHEMBL6167	Homo sapiens	IC50	uM	0.061
	19350486	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccnnc3)nc3cnccc23)CC1		CHEMBL4446094	=	IC50	nM	197.0	CHEMBL6167	Homo sapiens	IC50	uM	0.197
	19350487	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3cnco3)nc3cnccc23)CC1		CHEMBL4547989	=	IC50	nM	324.0	CHEMBL6167	Homo sapiens	IC50	uM	0.324
	19350488	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccn[nH]3)nc3cnccc23)CC1		CHEMBL4465737	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350489	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3cnc[nH]3)nc3cnccc23)CC1		CHEMBL4483614	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350490	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1cncc1-c1nc(NC2(C)CC2)c2ccncc2n1		CHEMBL4535052	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350491	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-n3ccc4ncccc43)nc3cnccc23)CC1		CHEMBL4529796	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350492	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3c[nH]nn3)nc3cnccc23)CC1		CHEMBL4467512	=	IC50	nM	322.0	CHEMBL6167	Homo sapiens	IC50	uM	0.322
	19350493	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1cc(-c2nc(NC3(C)CC3)c3ccncc3n2)on1		CHEMBL4469337	=	IC50	nM	9000.0	CHEMBL6167	Homo sapiens	IC50	uM	9.0
	19350494	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3nn[nH]n3)nc3cnccc23)CC1		CHEMBL4514307	>	IC50	nM	10000.0	CHEMBL6167	Homo sapiens	IC50	uM	10.0
	19350495	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(Nc1nc(-c2cn[nH]c2)nc2cnccc12)c1ccncc1		CHEMBL4462156	=	IC50	nM	797.0	CHEMBL6167	Homo sapiens	IC50	uM	0.797
	19350496	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1nccc1-c1nc(NC(C)(C)C)c2ccncc2n1		CHEMBL4579119	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350497	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]cc1-c1nc(NC2(CO)CCC2)c2ccncc2n1		CHEMBL4582642	=	IC50	nM	9.0	CHEMBL6167	Homo sapiens	IC50	uM	0.009
	19350498	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1nccc1-c1nc(NC2(C)CCC2)c2ccncc2n1		CHEMBL4534258	=	IC50	nM	9.0	CHEMBL6167	Homo sapiens	IC50	uM	0.009
	19350499	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1nccc1-c1nc(NC2(CO)CCC2)c2ccncc2n1		CHEMBL4437926	=	IC50	nM	16.0	CHEMBL6167	Homo sapiens	IC50	uM	0.016
	19350500	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C1(Nc2nc(-c3cn[nH]c3)nc3cnccc23)CC1		CHEMBL4448569	=	IC50	nM	17.0	CHEMBL6167	Homo sapiens	IC50	uM	0.017
	19350501	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1nccc1-c1nc(NC2(C(F)(F)F)CC2)c2ccncc2n1		CHEMBL4535305	=	IC50	nM	83.0	CHEMBL6167	Homo sapiens	IC50	uM	0.083
	19350502	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]cc1-c1nc(NC(C)c2ccncc2)c2ccncc2n1		CHEMBL4552005	=	IC50	nM	99.0	CHEMBL6167	Homo sapiens	IC50	uM	0.099
	19350503	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCC1(Nc2nc(-c3cn[nH]c3)nc3cnccc23)CCC1		CHEMBL4472859	=	IC50	nM	189.0	CHEMBL6167	Homo sapiens	IC50	uM	0.189
	19350504	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	OCC1(Nc2nc(-c3cn[nH]c3)nc3cnccc23)CC1		CHEMBL4456319	=	IC50	nM	201.0	CHEMBL6167	Homo sapiens	IC50	uM	0.201
	19350505	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(Nc1nc(-c2ccnn2C)nc2cnccc12)c1ccncc1		CHEMBL4554950	>	IC50	nM	10000.0	CHEMBL6167	Homo sapiens	IC50	uM	10.0
	19350506	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3cn[nH]c3)nc3cnccc23)CC1		CHEMBL4472003	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350507	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCn1cc(-c2nc(NCC(C)C)c3ccncc3n2)cn1		CHEMBL4447290	>	IC50	nM	10000.0	CHEMBL6167	Homo sapiens	IC50	uM	10.0
	19350508	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cn1cc(-c2nc(NC3(C)CC3)c3ccncc3n2)cn1		CHEMBL4575255	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350509	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CN)Nc1nc(-c2cn[nH]c2)nc2cnccc12		CHEMBL4476350	=	IC50	nM	23.0	CHEMBL6167	Homo sapiens	IC50	uM	0.023
	19350510	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncc3)nc3c(Cl)nccc23)CC1		CHEMBL4450439	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350511	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1nccc2c(NC3(C)CC3)nc(-c3ccncc3)nc12		CHEMBL4547932	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350512	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2ccncc2)nc2cncc(Cl)c12		CHEMBL4444003	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350513	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(Nc2nc(-c3ccncc3)nc3cncc(Cl)c23)CC1		CHEMBL4572928	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350514	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1nc(-c2ccncc2)nc2cncc(NCCOCCO)c12		CHEMBL4454374	=	IC50	nM	85.0	CHEMBL6167	Homo sapiens	IC50	uM	0.085
	19350515	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COCCC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4458233	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350516	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)OCC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4475201	=	IC50	nM	8.0	CHEMBL6167	Homo sapiens	IC50	uM	0.008
	19350517	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC[C@H](C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4538809	=	IC50	nM	8.0	CHEMBL6167	Homo sapiens	IC50	uM	0.008
	19350518	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC[C@@H](C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4461494	=	IC50	nM	22.0	CHEMBL6167	Homo sapiens	IC50	uM	0.022
	19350519	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	COCC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4471933	=	IC50	nM	23.0	CHEMBL6167	Homo sapiens	IC50	uM	0.023
	19350520	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)N(C)c1cc(-c2ccncc2)nc2cnccc12		CHEMBL4574675	=	IC50	nM	61.0	CHEMBL6167	Homo sapiens	IC50	uM	0.061
	19350521	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CCO)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4564095	=	IC50	nM	459.0	CHEMBL6167	Homo sapiens	IC50	uM	0.459
	19350522	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4454440	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350523	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(C)CC(O)CCN1c1cc(-c2ccncc2)nc2cnccc12		CHEMBL4436727	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350524	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)CC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4461250	=	IC50	nM	7.0	CHEMBL6167	Homo sapiens	IC50	uM	0.007
	19350525	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	c1cc(-c2cc(NC3CCCC3)c3ccncc3n2)ccn1		CHEMBL4442227	=	IC50	nM	7.0	CHEMBL6167	Homo sapiens	IC50	uM	0.007
	19350526	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(C)CCC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4544973	=	IC50	nM	8.0	CHEMBL6167	Homo sapiens	IC50	uM	0.008
	19350527	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(CC)c1cc(-c2ccncc2)nc2cnccc12		CHEMBL4450968	=	IC50	nM	9.0	CHEMBL6167	Homo sapiens	IC50	uM	0.009
	19350528	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(O)COCC(C)(C)Nc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4521564	=	IC50	nM	13.0	CHEMBL6167	Homo sapiens	IC50	uM	0.013
	19350529	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4437496	=	IC50	nM	18.0	CHEMBL6167	Homo sapiens	IC50	uM	0.018
	19350530	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Cc1n[nH]cc1-c1cc(NC(C)(C)C)c2ccncc2n1		CHEMBL4444109	=	IC50	nM	1.0	CHEMBL6167	Homo sapiens	IC50	uM	0.001
	19350531	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccncn2)nc2cnccc12		CHEMBL4438081	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350532	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccnc(N)n2)nc2cnccc12		CHEMBL4573735	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350533	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccnc3[nH]ccc23)nc2cnccc12		CHEMBL4456799	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350534	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccnnc2)nc2cnccc12		CHEMBL4435927	=	IC50	nM	463.0	CHEMBL6167	Homo sapiens	IC50	uM	0.463
	19350535	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccnc(N)c2)nc2cnccc12		CHEMBL4467968	=	IC50	nM	13.0	CHEMBL6167	Homo sapiens	IC50	uM	0.013
	19350536	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(CC)c1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4475654	=	IC50	nM	11.0	CHEMBL6167	Homo sapiens	IC50	uM	0.011
	19350537	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CN(C)CCC(C)(C)Nc1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4453187	=	IC50	nM	17.0	CHEMBL6167	Homo sapiens	IC50	uM	0.017
	19350538	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)N(C)c1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4576797	=	IC50	nM	65.0	CHEMBL6167	Homo sapiens	IC50	uM	0.065
	19350539	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Fc1cnccc1-c1cc(N2CCCCC2)c2ccncc2n1		CHEMBL4557740	=	IC50	nM	90.0	CHEMBL6167	Homo sapiens	IC50	uM	0.09
	19350540	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	Fc1cnccc1-c1cc(N2CCOCC2)c2ccncc2n1		CHEMBL4442599	>	IC50	nM	2500.0	CHEMBL6167	Homo sapiens	IC50	uM	2.5
	19350541	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4520021	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350542	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCC(C)(C)Nc1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4554641	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350543	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CO)Nc1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4455803	=	IC50	nM	10.0	CHEMBL6167	Homo sapiens	IC50	uM	0.01
	19350544	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC1(C)CC(O)CCN1c1cc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4561966	=	IC50	nM	20.0	CHEMBL6167	Homo sapiens	IC50	uM	0.02
	19350545	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(CN1CCOCC1)Nc1cc(-c2ccncc2F)nc2cnccc12		CHEMBL4437210	=	IC50	nM	30.0	CHEMBL6167	Homo sapiens	IC50	uM	0.03
	19350546	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CC(C)(C)Nc1cc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4458288	=	IC50	nM	190.0	CHEMBL6167	Homo sapiens	IC50	uM	0.19
	19350547	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCN(CC)c1cc(-c2ccncc2Cl)nc2cnccc12		CHEMBL4453008	=	IC50	nM	560.0	CHEMBL6167	Homo sapiens	IC50	uM	0.56
	19350548	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	CCCNc1nc(-c2c[nH]nc2C(F)(F)F)nc2cnccc12		CHEMBL4565580	=	IC50	nM	2.0	CHEMBL6167	Homo sapiens	IC50	uM	0.002
	19350549	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C1(Nc2nc(-c3ccncc3)cc3cnccc23)CC1		CHEMBL4449036	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350550	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C1(Nc2cc(-c3ccncc3)cc3cnccc23)CC1		CHEMBL4447885	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350551	CHEMBL4420660	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 30 mins by HTRF assay	B	FC(F)(F)C1CN(c2nc(-c3ccncc3)nc3cnccc23)CCN1		CHEMBL4522021	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350552	CHEMBL4420661	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 3 hrs in presence of FAM-KKLRRTLSVA-COOH by fluorescence detection based biochemical caliper assay	B	CCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4472817	=	IC50	nM	34.0	CHEMBL6167	Homo sapiens	IC50	uM	0.034
	19350553	CHEMBL4420661	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 3 hrs in presence of FAM-KKLRRTLSVA-COOH by fluorescence detection based biochemical caliper assay	B	CC(C)(O)CC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4533967	=	IC50	nM	12.0	CHEMBL6167	Homo sapiens	IC50	uM	0.012
	19350554	CHEMBL4420661	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 3 hrs in presence of FAM-KKLRRTLSVA-COOH by fluorescence detection based biochemical caliper assay	B	c1cc(-c2nc(NC3CCCC3)c3ccncc3n2)ccn1		CHEMBL4547445	=	IC50	nM	22.0	CHEMBL6167	Homo sapiens	IC50	uM	0.022
	19350555	CHEMBL4420661	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 3 hrs in presence of FAM-KKLRRTLSVA-COOH by fluorescence detection based biochemical caliper assay	B	Cc1n[nH]cc1-c1nc(NC2(C)CC2)c2ccncc2n1		CHEMBL4585067	=	IC50	nM	4.0	CHEMBL6167	Homo sapiens	IC50	uM	0.004
	19350556	CHEMBL4420661	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 3 hrs in presence of FAM-KKLRRTLSVA-COOH by fluorescence detection based biochemical caliper assay	B	CC(C)(Nc1nc(-c2ccncc2Cl)nc2cnccc12)C(F)(F)F		CHEMBL4513243	=	IC50	nM	28.0	CHEMBL6167	Homo sapiens	IC50	uM	0.028
	19350801	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN1CCN(c2cc(-c3ccncc3)nc3cnccc23)CC1		CHEMBL4438995	=	IC50	nM	457.0	CHEMBL6167	Homo sapiens	IC50	uM	0.457
	19350802	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	c1cc(-c2cc(N3CCNCC3)c3ccncc3n2)ccn1		CHEMBL4461247	=	IC50	nM	43.3	CHEMBL6167	Homo sapiens	IC50	uM	0.0433
	19350803	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1CCCCN1c1cc(-c2ccncc2)nc2cnccc12		CHEMBL4448179	=	IC50	nM	16.0	CHEMBL6167	Homo sapiens	IC50	uM	0.016
	19350804	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	FC(F)(F)C1(Nc2cc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4464441	=	IC50	nM	4.5	CHEMBL6167	Homo sapiens	IC50	uM	0.0045
	19350805	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(N)CNc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4440342	=	IC50	nM	10.0	CHEMBL6167	Homo sapiens	IC50	uM	0.01
	19350806	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	c1cc(-c2cc(NC3COC3)c3ccncc3n2)ccn1		CHEMBL4483670	=	IC50	nM	208.9	CHEMBL6167	Homo sapiens	IC50	uM	0.2089
	19350807	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1(Nc2cc(-c3ccncc3)nc3cnccc23)CC1		CHEMBL4566901	=	IC50	nM	7.5	CHEMBL6167	Homo sapiens	IC50	uM	0.0075
	19350808	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1(C)CN(c2cc(-c3ccncc3)nc3cnccc23)CCN1		CHEMBL4577411	=	IC50	nM	59.0	CHEMBL6167	Homo sapiens	IC50	uM	0.059
	19350809	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1(C)CN(c2cc(-c3ccncc3)nc3cnccc23)CCO1		CHEMBL4464722	=	IC50	nM	97.1	CHEMBL6167	Homo sapiens	IC50	uM	0.0971
	19350810	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1(Nc2cc(-c3ccncc3)nc3cnccc23)CCC1		CHEMBL4446217	=	IC50	nM	1.2	CHEMBL6167	Homo sapiens	IC50	uM	0.0012
	19350811	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(CN)CNc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4563473	=	IC50	nM	5.2	CHEMBL6167	Homo sapiens	IC50	uM	0.0052
	19350812	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)C(C)(C)CNc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4522691	=	IC50	nM	59.5	CHEMBL6167	Homo sapiens	IC50	uM	0.0595
	19350813	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1CNCCN1c1cc(-c2ccncc2)nc2cnccc12		CHEMBL4463799	=	IC50	nM	10.2	CHEMBL6167	Homo sapiens	IC50	uM	0.0102
	19350814	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(CN)CNc1cc(-c2ccncc2)nc2cnccc12		CHEMBL4448408	=	IC50	nM	9.6	CHEMBL6167	Homo sapiens	IC50	uM	0.0096
	19350815	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	FC(F)(F)[C@H]1CN(c2cc(-c3ccncc3)nc3cnccc23)CCN1		CHEMBL4551335	=	IC50	nM	662.9	CHEMBL6167	Homo sapiens	IC50	uM	0.6629
	19350816	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(c1cc(-c2ccncc2)nc2cnccc12)C(C)(C)C		CHEMBL4590309	=	IC50	nM	1.2	CHEMBL6167	Homo sapiens	IC50	uM	0.0012
	19350817	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC1(Nc2cc(-c3ccncn3)nc3cnccc23)CCC1		CHEMBL4483764	=	IC50	nM	1.9	CHEMBL6167	Homo sapiens	IC50	uM	0.0019
	19350818	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)CCC(C)(C)Nc1nc(-c2ccncn2)nc2cnccc12		CHEMBL4556611	=	IC50	nM	68.7	CHEMBL6167	Homo sapiens	IC50	uM	0.0687
	19350819	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	Cc1n[nH]cc1-c1nc(NC(C)(C)CCN(C)C)c2ccncc2n1		CHEMBL4525078	=	IC50	nM	0.8	CHEMBL6167	Homo sapiens	IC50	uM	0.0008
	19350820	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(CNc1nc(-c2ccncc2)nc2cnccc12)NC(=O)OC(C)(C)C		CHEMBL4444841	=	IC50	nM	163.9	CHEMBL6167	Homo sapiens	IC50	uM	0.1639
	19350821	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(C)OC(=O)NCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4442656	=	IC50	nM	1033.6	CHEMBL6167	Homo sapiens	IC50	uM	1.0336
	19350822	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(N)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL3338837	=	IC50	nM	2.4	CHEMBL6167	Homo sapiens	IC50	uM	0.0024
	19350823	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	NCCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL2147535	=	IC50	nM	3.8	CHEMBL6167	Homo sapiens	IC50	uM	0.0038
	19350824	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)C(=O)C(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4539019	=	IC50	nM	466.7	CHEMBL6167	Homo sapiens	IC50	uM	0.4667
	19350825	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(CCC(C)(C)N)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4472021	=	IC50	nM	5.0	CHEMBL6167	Homo sapiens	IC50	uM	0.005
	19350826	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(CNC(=O)OC(C)(C)C)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4565547	=	IC50	nM	42.5	CHEMBL6167	Homo sapiens	IC50	uM	0.0425
	19350827	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(CN)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4447153	=	IC50	nM	0.8	CHEMBL6167	Homo sapiens	IC50	uM	0.0008
	19350828	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(CC(N)=O)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4456826	=	IC50	nM	1.8	CHEMBL6167	Homo sapiens	IC50	uM	0.0018
	19350829	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	FC(F)(F)[C@H]1CN(c2nc(-c3ccncc3)nc3cnccc23)CCN1		CHEMBL4549171	=	IC50	nM	58.1	CHEMBL6167	Homo sapiens	IC50	uM	0.0581
	19350830	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(N)C(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4439972	=	IC50	nM	0.7	CHEMBL6167	Homo sapiens	IC50	uM	0.0007
	19350831	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	FC(F)(F)[C@@H]1CN(c2nc(-c3ccncc3)nc3cnccc23)CCN1		CHEMBL4476521	=	IC50	nM	3.8	CHEMBL6167	Homo sapiens	IC50	uM	0.0038
	19350832	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CCOC(=O)C(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4565212	=	IC50	nM	29.2	CHEMBL6167	Homo sapiens	IC50	uM	0.0292
	19350833	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)CC(C)(C)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4468766	=	IC50	nM	4.5	CHEMBL6167	Homo sapiens	IC50	uM	0.0045
	19350834	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(C)Nc1nc(-c2nonc2N)nc2cnccc12		CHEMBL4448628	=	IC50	nM	10.4	CHEMBL6167	Homo sapiens	IC50	uM	0.0104
	19350835	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)C(C)(C)CNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4439805	=	IC50	nM	3.7	CHEMBL6167	Homo sapiens	IC50	uM	0.0037
	19350836	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(Nc1nc(-c2ccncc2)nc2cnccc12)C(N)=O		CHEMBL4457273	=	IC50	nM	57.2	CHEMBL6167	Homo sapiens	IC50	uM	0.0572
	19350837	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	C[C@](O)(CNc1cc(-c2ccncc2)nc2cnccc12)C(F)(F)F		CHEMBL4470844	=	IC50	nM	125.1	CHEMBL6167	Homo sapiens	IC50	uM	0.1251
	19350838	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(CCNC(=O)OC(C)(C)C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4566717	=	IC50	nM	18.9	CHEMBL6167	Homo sapiens	IC50	uM	0.0189
	19350839	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)CC(C)(C)CN(C)c1nc(-c2ccncc2)nc2cnccc12		CHEMBL4465820	=	IC50	nM	3.0	CHEMBL6167	Homo sapiens	IC50	uM	0.003
	19350840	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CCN(CC)CCC(C)(C)Nc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4436919	=	IC50	nM	3.1	CHEMBL6167	Homo sapiens	IC50	uM	0.0031
	19350841	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)CCC(C)(C)Nc1nc(-c2ccnc(F)c2)nc2cnccc12		CHEMBL4461790	=	IC50	nM	10.5	CHEMBL6167	Homo sapiens	IC50	uM	0.0105
	19350842	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	Cc1n[nH]c(C)c1-c1nc(NC(C)(C)CCN(C)C)c2ccncc2n1		CHEMBL4459788	=	IC50	nM	7.6	CHEMBL6167	Homo sapiens	IC50	uM	0.0076
	19350843	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)CCC(C)(C)Nc1nc(-c2c[nH]nc2C(F)(F)F)nc2cnccc12		CHEMBL4476463	=	IC50	nM	2.3	CHEMBL6167	Homo sapiens	IC50	uM	0.0023
	19350844	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CN(C)CCC(C)(C)Nc1nc(-c2ccnc(N)c2)nc2cnccc12		CHEMBL4566594	=	IC50	nM	6.1	CHEMBL6167	Homo sapiens	IC50	uM	0.0061
Not Determined	19350845	CHEMBL4420663	Inhibition of human LATS1 kinase domain (589 to 1130 amino acids) incubated for 1 hr in presence of Fluo-SGKtide substrate by fluorescence detection based biochemical caliper assay	B	CC(C)(N)CCNc1nc(-c2ccncc2)nc2cnccc12		CHEMBL4527014		IC50			CHEMBL6167	Homo sapiens	IC50		
	20669034	CHEMBL4620283	Inhibition of biotinylated ligand binding to wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control	B	CN(C)[C@@H]1CC[C@@]2(C)[C@@H](CC[C@H]3[C@@H]4CC=C(c5cccc6cnccc56)[C@@]4(C)CC[C@@H]32)C1		CHEMBL4637601	>	Inhibition	%	80.0	CHEMBL6167	Homo sapiens	INH	%	80.0
	22423517	CHEMBL4674334	Inhibition of human LATS1 using KKRNRRLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	90.37	CHEMBL6167	Homo sapiens	Activity	%	90.37
	22423518	CHEMBL4674334	Inhibition of human LATS1 using KKRNRRLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	77.53	CHEMBL6167	Homo sapiens	Activity	%	77.53
	22843699	CHEMBL4720685	Inhibition of human LATS1 using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	13.3	CHEMBL6167	Homo sapiens	IC50	10^-8M	1.33
	22844048	CHEMBL4721034	Inhibition of human LATS1 assessed as residual activity using KKRNRRLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.66	CHEMBL6167	Homo sapiens	Activity	%	96.66
	22844916	CHEMBL4721591	Inhibition of wild-type human partial length LATS1 (Q678 to V1130 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	101.48	CHEMBL6167	Homo sapiens	Activity	%	101.48
	23120542	CHEMBL4804407	Inhibition of LATS1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	14700.0	CHEMBL6167	Homo sapiens	IC50	uM	14.7
	23120543	CHEMBL4804407	Inhibition of LATS1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	4800.0	CHEMBL6167	Homo sapiens	IC50	uM	4.8
	23120544	CHEMBL4804407	Inhibition of LATS1 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-1100.0	CHEMBL6167	Homo sapiens	IC50	uM	-1.1
	23120545	CHEMBL4804407	Inhibition of LATS1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	3900.0	CHEMBL6167	Homo sapiens	IC50	uM	3.9
	23120546	CHEMBL4804407	Inhibition of LATS1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	33800.0	CHEMBL6167	Homo sapiens	IC50	uM	33.8
	23120547	CHEMBL4804407	Inhibition of LATS1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	33100.0	CHEMBL6167	Homo sapiens	IC50	uM	33.1
	23121581	CHEMBL4804589	Inhibition of LATS1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL6167	Homo sapiens	INH	%	0.0
	23121582	CHEMBL4804589	Inhibition of LATS1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL6167	Homo sapiens	INH	%	0.0
	23121583	CHEMBL4804589	Inhibition of LATS1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL6167	Homo sapiens	INH	%	0.0
	23121584	CHEMBL4804589	Inhibition of LATS1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL6167	Homo sapiens	INH	%	0.0
	23121585	CHEMBL4804589	Inhibition of LATS1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL6167	Homo sapiens	INH	%	0.0
	23121586	CHEMBL4804589	Inhibition of LATS1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL6167	Homo sapiens	INH	%	0.0
	23122636	CHEMBL4804987	Inhibition of human LATS1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	76.0	CHEMBL6167	Homo sapiens	Activity	%	76.0
	23123331	CHEMBL4805575	Inhibition of human LATS1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL6167	Homo sapiens	Activity	%	100.0
	23123790	CHEMBL4806034	Inhibition of DNA-tagged human LATS1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL6167	Homo sapiens	Activity	%	100.0
	23124752	CHEMBL4806592	Inhibition of human LATS1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	89.0	CHEMBL6167	Homo sapiens	Activity	%	89.0
	23124753	CHEMBL4806592	Inhibition of human LATS1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	97.0	CHEMBL6167	Homo sapiens	Activity	%	97.0
Not Active	23317471	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23317939	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	89.0	CHEMBL6167	Homo sapiens	% Control	%	89.0
Not Active	23318606	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL6167	Homo sapiens	% Control	%	87.0
Not Active	23319089	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23319726	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23320201	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	75.2	CHEMBL6167	Homo sapiens	% Control	%	75.2
Not Active	23320879	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23321347	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23321977	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	77.0	CHEMBL6167	Homo sapiens	% Control	%	77.0
Not Active	23322445	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	57.0	CHEMBL6167	Homo sapiens	% Control	%	57.0
Not Active	23323134	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL6167	Homo sapiens	% Control	%	92.0
Not Active	23323602	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	65.0	CHEMBL6167	Homo sapiens	% Control	%	65.0
Not Active	23324456	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23325091	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	84.0	CHEMBL6167	Homo sapiens	% Control	%	84.0
Not Active	23325559	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	90.0	CHEMBL6167	Homo sapiens	% Control	%	90.0
Not Active	23326206	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	79.0	CHEMBL6167	Homo sapiens	% Control	%	79.0
Not Active	23326674	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	69.0	CHEMBL6167	Homo sapiens	% Control	%	69.0
Not Active	23327374	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	91.0	CHEMBL6167	Homo sapiens	% Control	%	91.0
Not Active	23327842	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	97.0	CHEMBL6167	Homo sapiens	% Control	%	97.0
Not Active	23328429	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	94.0	CHEMBL6167	Homo sapiens	% Control	%	94.0
Not Active	23328897	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23329843	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	81.0	CHEMBL6167	Homo sapiens	% Control	%	81.0
Not Active	23330311	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	78.0	CHEMBL6167	Homo sapiens	% Control	%	78.0
Not Active	23331067	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23331535	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23332122	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	83.9	CHEMBL6167	Homo sapiens	% Control	%	83.9
Not Active	23332588	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23333306	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	67.1	CHEMBL6167	Homo sapiens	% Control	%	67.1
Not Active	23333945	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23334413	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Slightly Active	23335392	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	42.0	CHEMBL6167	Homo sapiens	% Control	%	42.0
Not Active	23335860	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	69.0	CHEMBL6167	Homo sapiens	% Control	%	69.0
Not Active	23336487	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	96.0	CHEMBL6167	Homo sapiens	% Control	%	96.0
Not Active	23336955	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	89.0	CHEMBL6167	Homo sapiens	% Control	%	89.0
Not Active	23338036	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL6167	Homo sapiens	% Control	%	93.0
Not Active	23338504	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23339116	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	98.0	CHEMBL6167	Homo sapiens	% Control	%	98.0
Not Active	23339584	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	77.0	CHEMBL6167	Homo sapiens	% Control	%	77.0
Not Active	23340221	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	98.0	CHEMBL6167	Homo sapiens	% Control	%	98.0
Not Active	23340689	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23341346	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	72.0	CHEMBL6167	Homo sapiens	% Control	%	72.0
Not Active	23341814	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	93.0	CHEMBL6167	Homo sapiens	% Control	%	93.0
Slightly Active	23342430	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	48.0	CHEMBL6167	Homo sapiens	% Control	%	48.0
Not Active	23342898	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	58.0	CHEMBL6167	Homo sapiens	% Control	%	58.0
Not Active	23343528	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL6167	Homo sapiens	% Control	%	97.0
Not Active	23343996	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23344634	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	69.0	CHEMBL6167	Homo sapiens	% Control	%	69.0
Not Active	23345207	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23345675	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	99.0	CHEMBL6167	Homo sapiens	% Control	%	99.0
Not Active	23346252	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23346721	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23347323	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	59.3	CHEMBL6167	Homo sapiens	% Control	%	59.3
Not Active	23347812	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23348391	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	98.0	CHEMBL6167	Homo sapiens	% Control	%	98.0
Not Active	23348859	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	81.0	CHEMBL6167	Homo sapiens	% Control	%	81.0
Not Active	23349446	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23350064	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	93.0	CHEMBL6167	Homo sapiens	% Control	%	93.0
Not Active	23350532	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	71.0	CHEMBL6167	Homo sapiens	% Control	%	71.0
Not Active	23351137	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	69.0	CHEMBL6167	Homo sapiens	% Control	%	69.0
Not Active	23351605	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	61.0	CHEMBL6167	Homo sapiens	% Control	%	61.0
Not Active	23352629	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	96.0	CHEMBL6167	Homo sapiens	% Control	%	96.0
Not Active	23353097	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23353979	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	88.0	CHEMBL6167	Homo sapiens	% Control	%	88.0
Not Active	23354447	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	86.0	CHEMBL6167	Homo sapiens	% Control	%	86.0
Not Active	23355179	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	70.0	CHEMBL6167	Homo sapiens	% Control	%	70.0
Not Active	23355647	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	67.0	CHEMBL6167	Homo sapiens	% Control	%	67.0
Not Active	23356283	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	82.0	CHEMBL6167	Homo sapiens	% Control	%	82.0
Not Active	23356751	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	86.0	CHEMBL6167	Homo sapiens	% Control	%	86.0
Not Active	23357360	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23358007	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23358475	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	91.0	CHEMBL6167	Homo sapiens	% Control	%	91.0
Not Active	23359061	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23359659	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	74.0	CHEMBL6167	Homo sapiens	% Control	%	74.0
Not Active	23360127	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	69.0	CHEMBL6167	Homo sapiens	% Control	%	69.0
Not Active	23360712	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL6167	Homo sapiens	% Control	%	99.0
Not Active	23361180	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23361753	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	81.0	CHEMBL6167	Homo sapiens	% Control	%	81.0
Not Active	23362289	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23362757	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23364399	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	87.0	CHEMBL6167	Homo sapiens	% Control	%	87.0
Not Active	23364867	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23365606	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	76.0	CHEMBL6167	Homo sapiens	% Control	%	76.0
Not Active	23366149	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	89.0	CHEMBL6167	Homo sapiens	% Control	%	89.0
Not Active	23366739	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23367207	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23368085	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23368553	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	86.0	CHEMBL6167	Homo sapiens	% Control	%	86.0
Not Active	23369152	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23369620	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	95.0	CHEMBL6167	Homo sapiens	% Control	%	95.0
Not Active	23370588	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23371056	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	85.0	CHEMBL6167	Homo sapiens	% Control	%	85.0
Not Active	23371865	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	98.0	CHEMBL6167	Homo sapiens	% Control	%	98.0
Not Active	23372333	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
	23372774	CHEMBL4884739	LATS1(LAT1LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL6167	Homo sapiens	pIC50		6.0
	23373183	CHEMBL4885030	LATS1(LAT1LGRJ) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL6167	Homo sapiens	pIC50		6.0
Not Active	23375760	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	81.0	CHEMBL6167	Homo sapiens	% Control	%	81.0
Not Active	23376228	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	76.0	CHEMBL6167	Homo sapiens	% Control	%	76.0
Not Active	23376805	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	95.0	CHEMBL6167	Homo sapiens	% Control	%	95.0
Not Active	23377273	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	98.0	CHEMBL6167	Homo sapiens	% Control	%	98.0
Not Active	23378133	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	60.0	CHEMBL6167	Homo sapiens	% Control	%	60.0
Not Active	23378601	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	59.0	CHEMBL6167	Homo sapiens	% Control	%	59.0
Not Active	23379768	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23380236	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23380930	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	87.0	CHEMBL6167	Homo sapiens	% Control	%	87.0
Not Active	23381578	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL6167	Homo sapiens	% Control	%	100.0
Not Active	23382046	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	96.0	CHEMBL6167	Homo sapiens	% Control	%	96.0
Not Active	23382670	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	96.0	CHEMBL6167	Homo sapiens	% Control	%	96.0
Not Active	23383138	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	51.0	CHEMBL6167	Homo sapiens	% Control	%	51.0
Not Active	23384322	CHEMBL4887917	LATS1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	8.31	CHEMBL6167	Homo sapiens	% inhibition	%	8.31
Not Active	23385053	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	88.0	CHEMBL6167	Homo sapiens	% Control	%	88.0
Not Active	23385520	CHEMBL4879777	KinomeScan assay: inhibition of LATS1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	98.0	CHEMBL6167	Homo sapiens	% Control	%	98.0
